{"id":32829,"date":"2021-04-02T11:43:03","date_gmt":"2021-04-02T11:43:03","guid":{"rendered":"https:\/\/www.cfh.de\/?post_type=project&p=32829"},"modified":"2023-10-25T06:01:09","modified_gmt":"2023-10-25T06:01:09","slug":"riboxx-gmbh","status":"publish","type":"project","link":"https:\/\/www.cfh.de\/en\/project\/riboxx-gmbh\/","title":{"rendered":"TGFS RiboxX GmbH"},"content":{"rendered":"

[et_pb_section fb_built=“1″ specialty=“on“ _builder_version=“4.16″ _module_preset=“default“ width=“100%“ max_width=“100%“ module_alignment=“center“ inner_width=“100%“ inner_max_width=“80%“ custom_padding=“||0px|||“ animation_style=“slide“ animation_direction=“bottom“ animation_duration=“300ms“ animation_delay=“50ms“ animation_intensity_slide=“5%“ animation_starting_opacity=“10%“ animation_speed_curve=“ease-in“ global_colors_info=“{}“][et_pb_column type=“3_4″ specialty_columns=“3″ _builder_version=“4.16″ custom_padding=“|||“ global_colors_info=“{}“ custom_padding__hover=“|||“][et_pb_row_inner _builder_version=“4.16″ _module_preset=“default“ width=“100%“ max_width=“80%“ max_width_tablet=“100%“ max_width_phone=“100%“ max_width_last_edited=“on|tablet“ module_alignment=“left“ custom_padding=“0px||||false|false“ animation_direction=“bottom“ module_alignment_tablet=“center“ module_alignment_phone=““ module_alignment_last_edited=“on|tablet“ global_colors_info=“{}“][et_pb_column_inner saved_specialty_column_type=“3_4″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_image src=“https:\/\/www.cfh.de\/wp-content\/uploads\/2023\/10\/Riboxx.png“ alt=“RiboxX GmbH“ title_text=“Riboxx“ force_fullwidth=“on“ _builder_version=“4.16.1″ _module_preset=“default“ hover_enabled=“0″ global_colors_info=“{}“ sticky_enabled=“0″][\/et_pb_image][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner _builder_version=“4.16″ _module_preset=“default“ width=“100%“ max_width=“80%“ max_width_tablet=“100%“ max_width_phone=“100%“ max_width_last_edited=“on|phone“ animation_direction=“bottom“ module_alignment_tablet=“center“ module_alignment_phone=““ module_alignment_last_edited=“on|tablet“ global_colors_info=“{}“][et_pb_column_inner saved_specialty_column_type=“3_4″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.16″ _module_preset=“default“ header_font=“Noto Sans|700|||||||“ header_text_color=“#495A66″ header_font_size=“22px“ header_2_font=“Noto Sans||||||||“ header_2_text_color=“#6E95B2″ header_2_font_size=“20px“ header_3_font=“Noto Sans||||||||“ header_3_text_color=“#495A66″ header_4_font=“Noto Sans||||||||“ header_4_text_color=“#6E95B2″ header_4_font_size=“20px“ global_colors_info=“{}“]<\/p>\n

Chem-\/Biotech<\/span><\/h4>\n

Bessere Adjuvanzien<\/h1>\n

RiboxX GmbH<\/span><\/h2>\n

[\/et_pb_text][et_pb_text _builder_version=“4.16″ _module_preset=“default“ text_font=“Noto Sans||||||||“ text_text_color=“#495A66″ text_font_size=“17px“ custom_margin=“-3px|||||“ text_font_size_tablet=““ text_font_size_phone=“14px“ text_font_size_last_edited=“on|phone“ global_colors_info=“{}“]<\/p>\n

RiboxX GmbH ist eine Ausgr\u00fcndung aus der TU Dresden und verf\u00fcgt \u00fcber eine patentierte Plattformtechnologie zur Produktion von doppelstr\u00e4ngiger RNA. Diese erm\u00f6glicht die Entwicklung und Produktion von neuartigen Adjuvanzien f\u00fcr Impfstoffe und Immuntherapeutika, bei deren Erprobung RiboxX mit verschiedenen Unternehmen weltweit zusammenarbeitet. Die Materialien k\u00f6nnen nach GMP-Richtlinien f\u00fcr die Anwendung in klinischen Studien hergestellt werden.<\/p>\n

Der TGFS ist seit 2009 am Unternehmen beteiligt.<\/p>\n

[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][et_pb_column type=“1_4″ _builder_version=“4.16″ custom_padding=“|||“ global_colors_info=“{}“ custom_padding__hover=“|||“][et_pb_image src=“https:\/\/www.cfh.de\/wp-content\/uploads\/2021\/04\/riboxx_.jpg“ alt=“RiboxX GmbH“ title_text=“RiboxX GmbH“ align=“center“ _builder_version=“4.16″ _module_preset=“default“ width=“100%“ max_width=“100%“ max_width_tablet=“60%“ max_width_phone=“60%“ max_width_last_edited=“on|desktop“ custom_margin=“10%||30%||false|false“ custom_margin_tablet=“||0%||false|false“ custom_margin_phone=““ custom_margin_last_edited=“on|phone“ animation_direction=“bottom“ global_colors_info=“{}“][\/et_pb_image][et_pb_text _builder_version=“4.16″ _module_preset=“default“ text_font=“Noto Sans||||||||“ text_text_color=“#495A66″ text_font_size=“17px“ custom_margin=“|||10%|false|false“ custom_margin_tablet=“|||0%|false|false“ custom_margin_phone=““ custom_margin_last_edited=“on|tablet“ animation_direction=“bottom“ text_orientation_tablet=“center“ text_orientation_phone=““ text_orientation_last_edited=“on|tablet“ global_colors_info=“{}“]<\/p>\n

Status<\/strong>
Aktiv<\/p>\n

[\/et_pb_text][et_pb_text _builder_version=“4.16″ _module_preset=“default“ text_font=“Noto Sans||||||||“ text_text_color=“#495A66″ text_font_size=“17px“ custom_margin=“|||10%|false|false“ custom_margin_tablet=“|||0%|false|false“ custom_margin_phone=““ custom_margin_last_edited=“on|tablet“ animation_direction=“bottom“ text_orientation_tablet=“center“ text_orientation_phone=““ text_orientation_last_edited=“on|tablet“ global_colors_info=“{}“]<\/p>\n

Segment<\/strong>
Fr\u00fchphase<\/p>\n

[\/et_pb_text][et_pb_text _builder_version=“4.16″ _module_preset=“default“ text_font=“Noto Sans||||||||“ text_text_color=“#495A66″ text_font_size=“17px“ custom_margin=“|||10%|false|false“ custom_margin_tablet=“|||0%|false|false“ custom_margin_phone=““ custom_margin_last_edited=“on|tablet“ animation_direction=“bottom“ text_orientation_tablet=“center“ text_orientation_phone=““ text_orientation_last_edited=“on|tablet“ global_colors_info=“{}“]<\/p>\n

Sitz\u00a0<\/strong>
Dresden<\/p>\n

[\/et_pb_text][et_pb_text _builder_version=“4.16″ _module_preset=“default“ text_font=“Noto Sans||||||||“ text_text_color=“#495A66″ text_font_size=“17px“ link_font=“Noto Sans||||||||“ link_text_color=“#9CC007″ custom_margin=“|||10%|false|false“ custom_margin_tablet=“|||0%|false|false“ custom_margin_phone=““ custom_margin_last_edited=“on|tablet“ animation_direction=“bottom“ link_option_url_new_window=“on“ text_orientation_tablet=“center“ text_orientation_phone=““ text_orientation_last_edited=“on|tablet“ global_colors_info=“{}“]<\/p>\n

Website
<\/strong>www.riboxx.com<\/a><\/span><\/p>\n

[\/et_pb_text][et_pb_text _builder_version=“4.16.1″ _module_preset=“default“ text_font=“Noto Sans||||||||“ text_text_color=“#495A66″ text_font_size=“17px“ link_font=“Noto Sans||||||||“ link_text_color=“#9CC007″ custom_margin=“|||10%|false|false“ custom_margin_tablet=“|||0%|false|false“ custom_margin_phone=““ custom_margin_last_edited=“on|tablet“ animation_direction=“bottom“ text_orientation_tablet=“center“ text_orientation_phone=““ text_orientation_last_edited=“on|tablet“ global_colors_info=“{}“]<\/p>\n

TGFS-Team
<\/strong>Dr. Matthias Kalbus<\/a>
<\/span>S\u00f6ren Schuster<\/a><\/span><\/p>\n

<\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_section][et_pb_section fb_built=“1″ _builder_version=“4.16″ _module_preset=“default“ width=“100%“ max_width=“80%“ max_width_tablet=“100%“ max_width_phone=“100%“ max_width_last_edited=“on|tablet“ module_alignment=“center“ custom_padding=“0px||0px||false|false“ global_colors_info=“{}“][et_pb_row column_structure=“1_2,1_2″ module_class=“tablet-two-cols phone-two-cols“ _builder_version=“4.16″ _module_preset=“default“ width=“100%“ max_width=“59%“ max_width_tablet=“80%“ max_width_phone=““ max_width_last_edited=“on|tablet“ module_alignment=“left“ custom_margin_tablet=“5%||||false|false“ custom_margin_phone=““ custom_margin_last_edited=“on|tablet“ module_alignment_tablet=“center“ module_alignment_phone=““ module_alignment_last_edited=“on|tablet“ global_colors_info=“{}“][et_pb_column type=“1_2″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_button button_url=“@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjMyNTYyIn19@“ button_text=“zur \u00dcbersicht“ button_alignment=“left“ button_text_tablet=“zur \u00dcbersicht“ button_text_phone=“\u00dcbersicht“ button_text_last_edited=“on|tablet“ module_class=“mobile-two-cols button_left“ _builder_version=“4.16″ _dynamic_attributes=“button_url“ _module_preset=“default“ custom_button=“on“ button_text_size=“17px“ button_text_color=“#495A66″ button_border_width=“0px“ button_font=“|700|||||||“ button_icon=“4||divi||400″ button_icon_placement=“left“ button_on_hover=“off“ custom_padding=“||||false|false“ button_text_size_tablet=““ button_text_size_phone=“17px“ button_text_size_last_edited=“on|desktop“ button_bg_color_tablet=““ button_bg_color_phone=““ button_bg_color_last_edited=“on|desktop“ global_colors_info=“{}“ button_bg_color__hover_enabled=“on|hover“ button_bg_color__hover=“#FFFFFF“ button_bg_enable_color__hover=“on“ custom_css_main_element_last_edited=“on|desktop“][\/et_pb_button][\/et_pb_column][et_pb_column type=“1_2″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_button button_url=“http:\/\/www.riboxx.com“ url_new_window=“on“ button_text=“zum Unternehmen“ button_alignment=“right“ button_text_tablet=“zum Unternehmen“ button_text_phone=“Unternehmen“ button_text_last_edited=“on|tablet“ _builder_version=“4.16″ _module_preset=“default“ custom_button=“on“ button_text_size=“17px“ button_text_color=“#495A66″ button_border_width=“0px“ button_font=“|700|||||||“ button_icon=“5||divi||400″ button_on_hover=“off“ button_text_size_tablet=““ button_text_size_phone=“17px“ button_text_size_last_edited=“on|tablet“ global_colors_info=“{}“ button_bg_color__hover_enabled=“on|hover“ button_bg_color__hover=“RGBA(0,0,0,0)“ button_bg_enable_color__hover=“on“][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

RiboxX GmbH is a spin-off from the TU Dresden and has a patented platform technology for the production of double-stranded RNA. This enables the development and production of novel adjuvants for vaccines and immunotherapeutics, which RiboxX is collaborating with various companies worldwide to test. The materials can be manufactured according to GMP guidelines for use in clinical trials. <\/p>","protected":false},"author":5,"featured_media":32683,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_custom_body_class":"","_custom_post_class":"","wp_typography_post_enhancements_disabled":false,"footnotes":""},"project_category":[21],"project_tag":[],"class_list":["post-32829","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-tgfs"],"yoast_head":"\nTGFS RiboxX GmbH - CFH<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cfh.de\/en\/project\/riboxx-gmbh\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TGFS RiboxX GmbH - CFH\" \/>\n<meta property=\"og:description\" content=\"RiboxX GmbH ist eine Ausgr\u00fcndung aus der TU Dresden und verf\u00fcgt \u00fcber eine patentierte Plattformtechnologie zur Produktion von doppelstr\u00e4ngiger RNA. Diese erm\u00f6glicht die Entwicklung und Produktion von neuartigen Adjuvanzien f\u00fcr Impfstoffe und Immuntherapeutika, bei deren Erprobung RiboxX mit verschiedenen Unternehmen weltweit zusammenarbeitet. Die Materialien k\u00f6nnen nach GMP-Richtlinien f\u00fcr die Anwendung in klinischen Studien hergestellt werden.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cfh.de\/en\/project\/riboxx-gmbh\/\" \/>\n<meta property=\"og:site_name\" content=\"CFH\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-25T06:01:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cfh.de\/wp-content\/uploads\/2021\/03\/riboxx_.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cfh.de\\\/project\\\/riboxx-gmbh\\\/\",\"url\":\"https:\\\/\\\/www.cfh.de\\\/project\\\/riboxx-gmbh\\\/\",\"name\":\"TGFS RiboxX GmbH - CFH\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cfh.de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cfh.de\\\/project\\\/riboxx-gmbh\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cfh.de\\\/project\\\/riboxx-gmbh\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cfh.de\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/riboxx_.jpg\",\"datePublished\":\"2021-04-02T11:43:03+00:00\",\"dateModified\":\"2023-10-25T06:01:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cfh.de\\\/project\\\/riboxx-gmbh\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cfh.de\\\/project\\\/riboxx-gmbh\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cfh.de\\\/project\\\/riboxx-gmbh\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cfh.de\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/riboxx_.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cfh.de\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/riboxx_.jpg\",\"width\":500,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cfh.de\\\/project\\\/riboxx-gmbh\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.cfh.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projekte\",\"item\":\"https:\\\/\\\/www.cfh.de\\\/project\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"TGFS RiboxX GmbH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cfh.de\\\/#website\",\"url\":\"https:\\\/\\\/www.cfh.de\\\/\",\"name\":\"CFH\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cfh.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TGFS RiboxX GmbH \u2014 CFH","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cfh.de\/en\/project\/riboxx-gmbh\/","og_locale":"en_US","og_type":"article","og_title":"TGFS RiboxX GmbH - CFH","og_description":"RiboxX GmbH ist eine Ausgr\u00fcndung aus der TU Dresden und verf\u00fcgt \u00fcber eine patentierte Plattformtechnologie zur Produktion von doppelstr\u00e4ngiger RNA. Diese erm\u00f6glicht die Entwicklung und Produktion von neuartigen Adjuvanzien f\u00fcr Impfstoffe und Immuntherapeutika, bei deren Erprobung RiboxX mit verschiedenen Unternehmen weltweit zusammenarbeitet. Die Materialien k\u00f6nnen nach GMP-Richtlinien f\u00fcr die Anwendung in klinischen Studien hergestellt werden.","og_url":"https:\/\/www.cfh.de\/en\/project\/riboxx-gmbh\/","og_site_name":"CFH","article_modified_time":"2023-10-25T06:01:09+00:00","og_image":[{"width":500,"height":300,"url":"https:\/\/www.cfh.de\/wp-content\/uploads\/2021\/03\/riboxx_.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cfh.de\/project\/riboxx-gmbh\/","url":"https:\/\/www.cfh.de\/project\/riboxx-gmbh\/","name":"TGFS RiboxX GmbH \u2014 CFH","isPartOf":{"@id":"https:\/\/www.cfh.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cfh.de\/project\/riboxx-gmbh\/#primaryimage"},"image":{"@id":"https:\/\/www.cfh.de\/project\/riboxx-gmbh\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cfh.de\/wp-content\/uploads\/2021\/03\/riboxx_.jpg","datePublished":"2021-04-02T11:43:03+00:00","dateModified":"2023-10-25T06:01:09+00:00","breadcrumb":{"@id":"https:\/\/www.cfh.de\/project\/riboxx-gmbh\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cfh.de\/project\/riboxx-gmbh\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cfh.de\/project\/riboxx-gmbh\/#primaryimage","url":"https:\/\/www.cfh.de\/wp-content\/uploads\/2021\/03\/riboxx_.jpg","contentUrl":"https:\/\/www.cfh.de\/wp-content\/uploads\/2021\/03\/riboxx_.jpg","width":500,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/www.cfh.de\/project\/riboxx-gmbh\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.cfh.de\/"},{"@type":"ListItem","position":2,"name":"Projekte","item":"https:\/\/www.cfh.de\/project\/"},{"@type":"ListItem","position":3,"name":"TGFS RiboxX GmbH"}]},{"@type":"WebSite","@id":"https:\/\/www.cfh.de\/#website","url":"https:\/\/www.cfh.de\/","name":"CFH","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cfh.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/project\/32829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/comments?post=32829"}],"version-history":[{"count":15,"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/project\/32829\/revisions"}],"predecessor-version":[{"id":43792,"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/project\/32829\/revisions\/43792"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/media\/32683"}],"wp:attachment":[{"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/media?parent=32829"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/project_category?post=32829"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/www.cfh.de\/en\/wp-json\/wp\/v2\/project_tag?post=32829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}